Which triad of findings defines the classic opioid toxidrome?
Choose an answer, then check it.
Clinical Pharmacology · Toxicology and Antidotes
Opioid Overdose
On this page 6 sections
In 30 seconds
Opioid overdose kills through hypoxia, not sedation itself: breathing slows, stops, and the brain and heart run out of oxygen. The classic toxidrome is a triad — central nervous system depression, respiratory depression, and pinpoint pupils. The emergency response is airway and breathing first, naloxone second, and continued observation always, because naloxone wears off faster than most opioids do.
The college version
Recognizing the toxidrome
A toxidrome is a recognizable cluster of findings that points to a class of poisoning before any lab result comes back. The opioid toxidrome is the triad of depressed level of consciousness, respiratory depression (a slow, shallow rate with rising carbon dioxide), and miosis (constricted, "pinpoint" pupils). Picture a person found slumped in a chair, unresponsive to voice, breathing only a few times a minute, with pupils barely visible — that presentation should immediately raise suspicion for opioid toxicity. This pattern is distinguished at the bedside from other common toxidromes: sedative-hypnotic toxicity (benzodiazepines, alcohol) causes similar sedation but usually without significant miosis or the same degree of respiratory drive suppression; sympathomimetic toxicity (stimulants) produces agitation, tachycardia, hypertension, and dilated pupils — essentially the opposite picture; anticholinergic toxicity causes dilated pupils, dry flushed skin, delirium, and urinary retention; and cholinergic toxicity (as in organophosphate poisoning) produces excessive secretions, sweating, small pupils, and muscle fasciculations alongside bradycardia. Correctly sorting which pattern is present guides both the immediate response and the search for co-ingestions that may complicate the picture.
Why airway comes before antidote
The lethal mechanism in opioid overdose is hypoxia: respiratory depression reduces oxygen delivery to the brain and heart, and it is this oxygen deprivation — not sedation on its own — that causes death, anoxic brain injury, and cardiac arrest. This is why the emergency sequence always starts with the fundamentals rather than jumping straight to medication. The sequence is: assess responsiveness and breathing; open the airway and provide rescue breathing or bag-mask ventilation if breathing is absent or inadequate; call for emergency help; and administer naloxone by an available route — intranasal, intramuscular, or intravenous — repeating as needed until ventilation improves. Ventilating an unresponsive person buys time even before any antidote is on board, and it remains necessary support while naloxone takes effect and while its effects are monitored afterward.
Naloxone: what it does and does not do
Naloxone is a competitive opioid receptor antagonist that displaces opioid molecules from their receptors, reversing respiratory depression and sedation. Two features of its pharmacology matter clinically. First, naloxone's duration of action is generally shorter than that of most opioids, so a person can resedate and stop breathing again after an initial response — meaning anyone who receives naloxone needs continued observation, not a single dose and discharge. Second, high-potency synthetic opioids can require repeated dosing or continuous administration to sustain adequate breathing, since their potency and duration can outlast a standard response. Naloxone reverses opioid effects specifically; it will not reverse toxicity from co-ingested substances such as benzodiazepines, alcohol, or stimulants, so a person who remains altered or unstable after adequate reversal needs evaluation for something else on board.
Precipitated withdrawal and the goal of titration
In a person who is opioid-tolerant, naloxone can trigger precipitated withdrawal — a rapid onset of symptoms such as agitation, nausea, sweating, and generalized discomfort. This is intensely unpleasant but not itself life-threatening, unlike the overdose it interrupts. Because of this, the guiding principle is to titrate naloxone to adequate spontaneous ventilation, not to full alertness — giving only what is needed to restore safe breathing minimizes withdrawal severity while still addressing the danger.
Complications and secondary prevention
Overdose survivors can develop aspiration pneumonia when vomiting occurs during depressed consciousness and airway reflexes are blunted, non-cardiogenic pulmonary edema, and — from prolonged immobility that compresses a limb — rhabdomyolysis and compartment syndrome, both of which can threaten the limb and the kidneys if unrecognized. Prolonged hypoxia before rescue can cause lasting hypoxic brain injury, underscoring again why early ventilation matters as much as the antidote itself. Prevention efforts extend beyond the acute event: take-home naloxone programs put the antidote directly in the hands of people who use opioids, their families, and their communities; connection to treatment for opioid use disorder using medications such as buprenorphine and methadone represents legitimate, evidence-based, life-saving therapy rather than a substitute addiction; and Good Samaritan laws in many jurisdictions generally offer some legal protection to those who seek help during an overdose, encouraging bystanders to call for help without fear of legal consequence.
Eli explains
The same idea, in plain words
Explain it like I’m 10
Imagine breathing is like keeping a candle lit — your body needs a steady flow of air to keep going. Some pain medicines, when there's too much in the body, tell the brain to slow that breathing way down, like cupping a hand over the candle. If it slows too much, the flame can go out. The most important first move isn't a medicine at all — it's helping the person breathe, the way you'd blow gently on a dying flame to keep it lit, and calling an adult for help right away. There's also a rescue medicine that can push the "slow down" signal off the switch so breathing speeds back up. But that medicine doesn't last as long as the original problem, so the person still needs someone watching them for a while, in case the sleepy, slow-breathing feeling creeps back like the candle flickering low again.
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
A bystander finds someone unresponsive with slow, shallow breathing after suspected opioid use, and naloxone is not yet available. What should the bystander do first, and why?
Show answer
Open the airway and give rescue breaths or bag-mask ventilation while calling for emergency help.
Since low oxygen is what actually causes harm, keeping air moving into the person matters even before any medicine arrives, and getting trained help on the way is essential.
An opioid-tolerant patient becomes agitated and uncomfortable shortly after receiving naloxone but is now breathing adequately. Is this an emergency requiring more naloxone, and why or why not?
Show answer
No — the goal is adequate breathing, and precipitated withdrawal is unpleasant but not dangerous by itself.
Once the person is breathing well, giving more naloxone would only worsen the withdrawal discomfort without adding a safety benefit, so care shifts to comfort and continued monitoring.
Quick check
3 questions here. Answers stay hidden until you check.
What is the primary reason opioid overdose is life-threatening?
Choose an answer, then check it.
Why does someone who responds well to naloxone still need observation afterward?
Choose an answer, then check it.
Study tools & related lessonsRelated
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.